Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-17-028769
Filing Date
2017-07-26
Accepted
2017-07-26 18:37:59
Documents
2
Period of Report
2017-07-26

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 7951
2 poa_burow.htm EX-24 8853
  Complete submission text file 0001140361-17-028769.txt   18268
Mailing Address 8755 W. HIGGINS ROAD SUITE 1025 CHICAGO IL 60631
Business Address
Burow Kristina (Reporting) CIK: 0001569248 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38155 | Film No.: 17983994

Mailing Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362
Business Address 30699 RUSSELL RANCH ROAD, SUITE 140 WESTLAKE VILLAGE CA 91362 (818) 629-2256
Sienna Biopharmaceuticals, Inc. (Issuer) CIK: 0001656328 (see all company filings)

EIN.: 273364627 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations